DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Letairis (Ambrisentan) - Current Clinical Trials

 
 



Letairis Related Clinical Trials

A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis [Active, not recruiting]

The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study [Not yet recruiting]

Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial [Recruiting]

Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet [Completed]

The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers [Completed]

A Study to Test the Safety of Combined Dosing With Aminophylline and Ambrisentan in Exercising Healthy Human Volunteers at Simulated High Altitude [Completed]

Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension [Completed]

ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis [Terminated]

Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1) [Completed]

Study of Ambrisentan in Subjects With Pulmonary Hypertension [Active, not recruiting]

A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202) [Completed]

Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis [Recruiting]

(ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF [Terminated]

Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension [Recruiting]

Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertension [Completed]

Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension [Recruiting]

A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) [Recruiting]

A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) [Completed]

Ambrisentan for Treatment of Portopulmonary Hypertension [Recruiting]

Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension [Completed]

Ambrisentan in Single Ventricle [Recruiting]

Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension [Completed]

Ambrisentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension. [Recruiting]

Drug Use Investigation for VOLIBRIS� (Ambrisentan) (Pulmonary Arterial Hypertension) [Active, not recruiting]

Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan [Recruiting]

Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan [Terminated]

Influence of Cytochrome CYP3A4-induction by St. John's Wort on the Steady State Pharmacokinetics of Ambrisentan [Completed]

Efficacy Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH) [Completed]

An Observational Study For Ambrisentan [Completed]

Pharmacogenomics in Pulmonary Arterial Hypertension [Recruiting]

The Effects of Ambrisentan on Exercise Capacity in Fontan Patients [Completed]

Efficacy and Safety of Ambrisentan in Children 8-18yrs [Suspended]

An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Patients With Exercise Induced Pulmonary Arterial Hypertension [Recruiting]

Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529 [Recruiting]

Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension. [Completed]

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH) [Completed]

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension. [Completed]

Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension [Completed]

A Study to Evaluate the Efficacy of an Oral Medication in the Treatment and Prevention of Digital Ulcers in Patients With Systemic Sclerosis (Scleroderma). [Completed]

Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma [Not yet recruiting]

Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH) [Recruiting]

Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso� Compared to Other FDA Approved PAH Therapies [Completed]

Characterization and Detection of Prolonged Endothelin Receptors Antagonists Administration [Completed]

Drug Combination on Exercise Performance at High Altitude [Completed]

Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension [Completed]

Effect of Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on Medication Serum Levels and Clinical Disease Status in Patients With PAH [Recruiting]

Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH) [Recruiting]

COMPERA / COMPERA-KIDS [Recruiting]

A Study to Evaluate GSK1325760A - a Long-Term Extension Study [Completed]

Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH) [Active, not recruiting]

A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension [Completed]

Iloprost Power 15 in Pulmonary Arterial Hypertension [Completed]

A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses [Terminated]

Effects of Iloprost Treatment in Adult Patients With Pulmonary Arterial Hypertension Related to Congenital Heart Disease [Active, not recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015